Barely Significant
← all phrases

borderline significance

1,200 sentences · 1,200 papers · 11,068 search hits before verification

In the literature

borderline significanceP < .051.0× alpha
However, when adjusting for covariates, none of the cohorts of interest were associated with having a statistically significant difference in ADL difficulty, although borderline significance was seen for having stage III/IV difficulty when comparing nAMD vs control (OR, 0.74; 95% CI, 0.54-1.00; P < .05) ( Figure 2 ).
borderline significanceP = 0.051.0× alpha
On Cox regression, LVH showed borderline significance for independent association with all-cause mortality (hazard ratio 1.57, 95% CI 1.01–2.44, P = 0.05) after adjustment for age (predictive of death with hazard ratio 1.09, 95% CI 1.07–1.11, P < 0.005) and sex (predictive of death with hazard ratio 1.68, 95% CI 1.19–2.38, P < 0.005) (Fig. 1 ).
borderline significancep = 0.051.0× alpha
Pre-op LVEF was associated with the risk of post-op respiratory failure (OR 0.97, 95% CI 0.96–0.99, p = 0.01), whereas pre-op pulmonary hypertension showed borderline significance as a predictive factor (OR 2.01, 95% CI 0.98–4.09, p = 0.05). - Wound dehiscence and delirium Our logistic regression analysis revealed obesity was not a risk factor for either wound dehiscence or delirium (OR: 1.71, 95% CI: [0.885–3.336], p = 0.11; OR: 1.03, 95% CI: [0.34–3.13], p = 0.95, respectively).
borderline significancep = 0.051.0× alpha
Overall, PNP and NNP patients had a median of 5 neurologic manifestations or symptoms attributed to PASC, with significant age-related differences in PNP patients (median [IQR] number of symptoms: younger 6 [4–8], middle-age 5 [3–7], older 4 [2–6]; p = 0.001) and borderline significance in NNP patients (median [IQR] number of symptoms: younger 5 [3–7], middle-age 5 [3–7], older 4 [3–6]; p = 0.05), reflecting a lower number of neurologic symptoms in older patients.
borderline significancep-value = 0.051.0× alpha
Only 9.4% of individuals had already been diagnosed with COVID-19 prior to the infection that caused hospitalization, with no significant difference with the presence of post-COVID-19 syndrome 6 and 12 months after hospital discharge. However, among patients who were hospitalized due to recurrent COVID-19 infection, 64.7% had three or more symptoms after six months versus 34.4% of patients who had been hospitalized due to the first infection, with a borderline significance level (p-value = 0.05); but this difference was not observed 12 months after discharge.
borderline significanceP = 0.051.0× alpha
The score summarizing variants unrelated to complement or lipid metabolism was higher in AMD (mean ± SD = 0.03 ± 0.02) compared with AFVD (mean ± SD = −0.15 ± 0.05, P = 0.004), and showed a borderline significance level for being lower in AFVD compared with controls (mean ± SD = −0.02 ± 0.05, P = 0.05; Fig. 2 ).
borderline significancep = 0.051.0× alpha
BWLWH in STEP-AD compared to E-TAU had significantly higher ART adherence (estimate = 9.36 p = 0.045) and lower likelihood of being clinically diagnosed with PTSD (OR = .07, estimate = − 2.66, p = 0.03) as well as borderline significance on higher CD4 count (estimate = 161.26, p = 0.05).